{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:50:50Z","timestamp":1776837050098,"version":"3.51.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Remdesivir (RDV) is the first drug approved by the FDA for clinical treatment of hospitalized patients infected with COVID-19 because it has been shown to have good antiviral activity against a variety of viruses, including Arenaviridae and Coronaviridae viral families. However, it has been reported that its clinical treatment leads to the symptoms of sick sinus syndrome such as sinus bradycardia, conduction block, and sinus arrest, but the electrophysiological mechanism of its specific cardiac adverse events is still unclear. We report complementary, experimental, studies of its electrophysiological effects. In wireless cardiac telemetry experiments <jats:italic>in vivo<\/jats:italic> and electrocardiographic studies in <jats:italic>ex vivo<\/jats:italic> cardiac preparations, RDV significantly caused sinus bradycardia, sinus atrial block, and prolongation of the QT interval in guinea pigs. Dose-dependent effects of RDV on the electrical activities of sinoatrial node (SA node) preparations of guinea pigs were characterised by multielectrode, optical RH237 voltage mapping. These revealed reversibly reduced sinoatrial conduction time (SACT), increased AP durations (APDs), and decreased the pacemaking rate of the SA node. Patch-clamp experiments showed that RDV significantly inhibited the I<jats:sub>f<\/jats:sub> current of HCN4 channels, resulting in a significant decrease in the spontaneous firing rate of SA node cells, which may underlie the development of sick sinus node syndrome. In addition, RDV significantly inhibits I<jats:sub>Kr<\/jats:sub> currents in hERG channels, leading to prolongation of the QT interval and playing a role in bradycardia. Therefore, these findings provide insights into the understanding the bradycardia effect of RDV, which may be used as basic theoretical guidance for the intervention of its adverse events, and prompt safety investigations of RDV\u2019s cardiac safety in the future.<\/jats:p>","DOI":"10.3389\/fphys.2024.1436727","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T20:51:39Z","timestamp":1723755099000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Electrophysiological and sick sinus syndrome effects of Remdesivir challenge in guinea-pig hearts"],"prefix":"10.3389","volume":"15","author":[{"given":"Shuang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henggui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/hep.27488","article-title":"Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C","volume":"62","author":"Ahmad","year":"2015","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"7518","DOI":"10.3390\/jcm12247518","article-title":"Remdesivir-induced bradycardia and mortality in SARS-CoV-2 infection, potential risk factors assessment: a systematic review and meta-analysis","volume":"12","author":"Ai","year":"2023","journal-title":"J. Clin. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.14740\/cr1377","article-title":"Bradyarrhythmia after remdesivir administration in SARS-CoV-2: a review of literature and meta-analysis of observational studies in epidemiology","volume":"13","author":"Al-Jammali","year":"2022","journal-title":"Cardiol. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"645172","DOI":"10.3389\/fcvm.2021.645172","article-title":"In silico exploration of interactions between potential COVID-19 antiviral treatments and the pore of the hERG potassium channel-A drug antitarget","volume":"8","author":"Al-Moubarak","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"102393","DOI":"10.1016\/j.coph.2023.102393","article-title":"Adenosine signaling as target in cardiovascular pharmacology","volume":"71","author":"Antonioli","year":"2023","journal-title":"Curr. Opin. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1113\/jphysiol.1988.sp017352","article-title":"Ionic mechanisms of adenosine actions in pacemaker cells from rabbit heart","volume":"405","author":"Belardinelli","year":"1988","journal-title":"J. Physiology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"115783","DOI":"10.1016\/j.taap.2021.115783","article-title":"Remdesivir; molecular and functional measures of mitochondrial safety","volume":"433","author":"Bjork","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","article-title":"2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur. Heart J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e2255815","DOI":"10.1001\/jamanetworkopen.2022.55815","article-title":"Identification of bradycardia following remdesivir administration through the US food and drug administration American college of medical Toxicology COVID-19 toxic pharmacovigilance Project","volume":"6","author":"Devgun","year":"2023","journal-title":"JAMA Netw. open"},{"key":"B10","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"117","author":"De Wit","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"20220180","DOI":"10.1098\/rstb.2022.0180","article-title":"What makes the sinoatrial node tick? A question not for the faint of heart","volume":"378","author":"Donald","year":"2023","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.pbiomolbio.2022.11.005","article-title":"Pacemaker activity and ion channels in the sinoatrial node cells: MicroRNAs and arrhythmia","volume":"177","author":"Fan","year":"2023","journal-title":"Prog. Biophysics Mol. Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s004240050293","article-title":"The sustained inward current in sino-atrial node cells of Guinea-pig heart","volume":"433","author":"Guo","year":"1997","journal-title":"Pfl\u00fcgers Arch."},{"key":"B14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.vascn.2009.07.002","article-title":"Validation of a Guinea pig Langendorff heart model for assessing potential cardiovascular liability of drug candidates","volume":"60","author":"Guo","year":"2009","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1107198","DOI":"10.3389\/fphar.2022.1107198","article-title":"Remdesivir associated sinus bradycardia in patients with COVID-19: a prospective longitudinal study","volume":"13","author":"Hajimoradi","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF00656997","article-title":"Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches","volume":"391","author":"Hamill","year":"1981","journal-title":"Pflugers Arch."},{"key":"B17","doi-asserted-by":"publisher","first-page":"925042","DOI":"10.3389\/fphys.2022.925042","article-title":"Demographic and methodological heterogeneity in electrocardiogram signals from Guinea pigs","volume":"13","author":"Haq","year":"2022","journal-title":"Front. Physiology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1085\/jgp.92.2.145","article-title":"Muscarinic activation of ionic currents measured by a new whole-cell recording method","volume":"92","author":"Horn","year":"1988","journal-title":"J. General Physiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/BF00584963","article-title":"Calcium tolerant ventricular myocytes prepared by preincubation in a \u201cKB medium\u201d","volume":"395","author":"Isenberg","year":"1982","journal-title":"Pflugers Arch."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e222462","DOI":"10.1148\/radiol.222462","article-title":"Current and emerging knowledge in COVID-19","volume":"306","author":"Jeong","year":"2023","journal-title":"Radiology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.14423\/SMJ.0000000000001519","article-title":"Remdesivir-induced bradycardia","volume":"116","author":"Kanagala","year":"2023","journal-title":"South. Med. J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1111\/j.1476-5381.2012.01914.x","article-title":"Inhibitory effects of sevoflurane on pacemaking activity of sinoatrial node cells in Guinea-pig heart","volume":"166","author":"Kojima","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jacc.2018.10.043","article-title":"2018 ACC\/AHA\/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines, and the heart rhythm society","volume":"74","author":"Kusumoto","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1093\/cvr\/cvab311","article-title":"Remdesivir induces persistent mitochondrial and structural damage in human induced pluripotent stem cell derived cardiomyocytes","volume":"118","author":"Kwok","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e001622","DOI":"10.1128\/CMR.00162-20","article-title":"Remdesivir against COVID-19 and other viral diseases","volume":"34","author":"Malin","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s12012-021-09703-9","article-title":"Potential cardiotoxic effects of remdesivir on cardiovascular system: a literature review","volume":"22","author":"Nabati","year":"2022","journal-title":"Cardiovasc. Toxicol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.2147\/IDR.S362946","article-title":"Safety and efficacy of antiviral drugs for the treatment of COVID-19: a systematic review","volume":"15","author":"Nie","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"B28","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/FJC.0000000000001321","article-title":"Remdesivir (VEKLURY) for treating COVID-19: Guinea pig ex vivo and in vivo cardiac electrophysiological effects","volume":"80","author":"Pilote","year":"2022","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1158\/2159-8290.CD-20-0941","article-title":"Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and cancer consortium (CCC19) cohort study","volume":"10","author":"Rivera","year":"2020","journal-title":"Cancer Discov."},{"key":"B30","doi-asserted-by":"publisher","first-page":"eaal3653","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/2168479018795117","article-title":"Comprehensive in vitro proarrhythmia assay (CiPA) update from a cardiac safety research consortium\/health and environmental sciences institute\/FDA meeting","volume":"53","author":"Strauss","year":"2019","journal-title":"Ther. Innovation Regul. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1124\/jpet.120.000484","article-title":"COVID-19 drugs chloroquine and hydroxychloroquine, but not azithromycin and remdesivir, block hERG potassium channels","volume":"377","author":"Szendrey","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1021\/acsptsci.1c00166","article-title":"Electrophysiological and proarrhythmic effects of hydroxychloroquine challenge in Guinea-pig hearts","volume":"4","author":"Wang","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-2423-5","article-title":"Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2","volume":"585","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s12012-024-09872-3","article-title":"Electrophysiological profile of different antiviral therapies in a rabbit whole-heart model","volume":"24","author":"Wolfes","year":"2024","journal-title":"Cardiovasc. Toxicol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"971890","DOI":"10.3389\/fphar.2022.971890","article-title":"Remdesivir in treating hospitalized patients with COVID-19: a renewed review of clinical trials","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2024.1436727\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T20:51:45Z","timestamp":1723755105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2024.1436727\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":37,"alternative-id":["10.3389\/fphys.2024.1436727"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2024.1436727","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"article-number":"1436727"}}